New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - desmopressin acetate trihydrate 0.1mg equivalent to desmopressin 0.0890 mg;   - tablet - 100 mcg - active: desmopressin acetate trihydrate 0.1mg equivalent to desmopressin 0.0890 mg   excipient: lactose monohydrate magnesium stearate maize starch povidone

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - desmopressin acetate trihydrate 0.2mg equivalent to desmopressin 0.178 mg;   - tablet - 200 mcg - active: desmopressin acetate trihydrate 0.2mg equivalent to desmopressin 0.178 mg   excipient: lactose monohydrate magnesium stearate maize starch povidone

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 0.2 mg (equivalent: desmopressin, qty 178 microgram) - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; povidone; potato starch - minirin tablets are indicated for the treatment of: cranial diabetes insipidus; primary nocturnal enuresis, in patients from 6 years of age with normal ability to concentrate urine, who are refractory to an enuresis alarm, or in whom an enuresis alarm is contraindicated or inappropriate.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - desmopressin acetate trihydrate 0.6mg equivalent to desmopressin 0.089 mg/ml;   - nasal spray solution - 0.1 mg/ml - active: desmopressin acetate trihydrate 0.6mg equivalent to desmopressin 0.089 mg/ml   excipient: chlorobutanol hemihydrate hydrochloric acid nitrogen purified water sodium chloride

Israel - English - Ministry of Health

teva israel ltd - desmopressin acetate - tablets - desmopressin acetate 0.1 mg - desmopressin - desmopressin - desmopressin teva tablets are indicated for central diabetes insipidus, nocturnal enuresis ( in patients from 5 years of age with normal ability to concentrate the urine) and for symptomatic treatment of nocturia in adults associated with nocturnal polyuria, i.e. nocturnal urine production exceeding bladder capacity. the treatment must be started befor the age of 65.

Israel - English - Ministry of Health

teva israel ltd - desmopressin acetate - tablets - desmopressin acetate 0.2 mg - desmopressin - desmopressin - desmopressin teva tablets are indicated for central diabetes insipidus, nocturnal enuresis ( in patients from 5 years of age with normal ability to concentrate the urine) and for symptomatic treatment of nocturia in adults associated with nocturnal polyuria, i.e. nocturnal urine production exceeding bladder capacity. the treatment must be started befor the age of 65.

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 0.1 mg (equivalent: desmopressin, qty 89 microgram) - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; potato starch; povidone - minirin tablets are indicated for the treatment of: cranial diabetes insipidus; primary nocturnal enuresis, in patients from 6 years of age with normal ability to concentrate urine, who are refractory to an enuresis alarm, or in whom an enuresis alarm is contraindicated or inappropriate.

Ireland - English - HPRA (Health Products Regulatory Authority)

ferring ireland ltd - desmopressin acetate - tablet - 0.1 milligram(s) - vasopressin and analogues; desmopressin

Israel - English - Ministry of Health

ferring pharmaceuticals ltd - desmopressin acetate - tablets - desmopressin acetate 0.1 mg - desmopressin - desmopressin - central diabetes insipidus.nocturnal enuresis. treatment of nocturia in adults associated with nocturnal polyuria.

Malta - English - Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - desmopressin acetate - tablet - desmopressin acetate 100 µg - pituitary and hypothalamic hormones and analogues